Statistics

Total Visits

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis88

Select a period of time:

Number of views in the range

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis27

Views

Views
November 20251
December 20252
January 20262
February 20260
March 20263
April 202610
May 20269
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Argentina3
South Africa2
Mexico2
Brazil1
Spain1
France1
Italy1
Morocco1
Singapore1
 

Top cities views

Views
Booneville1
Clanton1
Cuiabá1
Córdoba1
Erlanger1
Iztacalco1
Jersey City1
Juárez1
Madrid1
Mar del Plata1